I. Avis

发表

Ingenuity Network-Assisted Transcription Profiling: Identification of a New Pharmacologic Mechanism for MK886

Anatoly L. Mayburd, J. Mulshine, Alfredo Martlínez, 2006, Clinical Cancer Research.

Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.

J. Minna, A. Gazdar, J. Mulshine, 1988, The Journal of clinical investigation.

Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancer.

J. Mulshine, I. Avis, J. Walsh, 1991, Journal of the National Cancer Institute.

Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer.

S. Larson, J. Mulshine, I. Avis, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Growth factors and other targets for rational application as intervention agents.

J. Mulshine, M. Birrer, I. Avis, 1992, Advances in experimental medicine and biology.

Strategies for lung cancer chemoprevention

J. Mulshine, I. Avis, F. Cuttitta, 1993 .

Scientific basis for cancer prevention intermediate cancer markers

J. Mulshine, I. Avis, M. Jett, 1993, Cancer.

Candidate biomarkers for applications as intermediate end points of lung carcinogenesis

J. Mulshine, M. Birrer, I. Avis, 1992, Journal of cellular biochemistry. Supplement.

The correct dose: pharmacologically guided end point for anti-growth factor therapy.

S. Larson, J. Mulshine, I. Avis, 1992, Cancer research.

Autocrine growth factors and lung cancer.

E. Sausville, J. Mulshine, I. Avis, 1989, Cancer treatment and research.

In vivo diagnosis and therapy of human tumors with monoclonal antibodies: selection of antibodies and preliminary clinical studies in small cell carcinoma of the lung.

S. Larson, J. Mulshine, I. Avis, 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Clinical Use of a Monoclonal Antibody to Bombesin‐like Peptide in Patients with Lung Cancer a, b

S. Larson, J. Minna, J. Mulshine, 1988, Annals of the New York Academy of Sciences.

Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo 1

T. Moody, J. Staley, J. Mulshine, 2006 .

Consideration of the Chemistry of Solid‐Phase Matrix Interactions Leads to Improved Quantitation of Neuropeptides a, b

J. Mulshine, I. Avis, Y. Nakanishi, 1988, Annals of the New York Academy of Sciences.

Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation.

J. Mulshine, I. Avis, Y. Nakanishi, 1988, Analytical biochemistry.

Non-peptide small molecule regulators of lymphangiogenesis.

I. Avis, F. Cuttitta, E. Zudaire, 2009, Lymphatic research and biology.

Five‐lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions

T. Moody, J. Mulshine, Yung-Hyun Choi, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Effect of gastrin‐releasing peptide on the pancreatic tumor cell line (capan)

J. Mulshine, I. Avis, M. Jett, 1993, Molecular carcinogenesis.

Alpha-amidation of peptide hormones in lung cancer.

J. Siegfried, J. Mulshine, I. Avis, 1991, Cancer cells.

Growth factor effects on small cell lung cancer cells using a colorimetric assay: can a transferrin-like factor mediate autocrine growth?

S. Steinberg, A. Gazdar, J. Mulshine, 1988, Experimental cell biology.

Randomized, Double-Blind, Placebo-Controlled Phase IIB Trial of the Cyclooxygenase Inhibitor Ketorolac as an Oral Rinse in Oropharyngeal Leukoplakia

S. Steinberg, S. Lippman, J. Mulshine, 2004, Clinical Cancer Research.

Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer.

J. Mulshine, M. Kelley, I. Avis, 1997, Chest.

Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: importance of bioavailability.

J. Mulshine, I. Avis, M. Miller, 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[Psi13,14] Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo

T. Moody, J. Staley, J. Mulshine, 1991 .

SCNH2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells.

W. Stetler-Stevenson, S. Hewitt, N. Held, 2013, Open journal of clinical diagnostics.

SCNH 2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells *

W. Stetler-Stevenson, S. Hewitt, N. Held, 2013 .

Autocrine growth factors as therapeutic targets in lung cancer.

J. Mulshine, I. Avis, Y. Nakanishi, 1989, Chest.

Effect of growth factors on the in vitro growth of small cell lung cancer as determined in a colorimetric assay

J. Minna, J. Mulshine, H. Kleinman, 1988 .

Novel Phenotypic Fluorescent Three-Dimensional Platforms for High-throughput Drug Screening and Personalized Chemotherapy

I. Avis, D. Salomon, F. Cuttitta, 2013, Journal of Cancer.

[Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.

T. Moody, J. Staley, J. Mulshine, 1991, Cancer research.